Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Veracyte (VCYT) Shares Outstanding (2016 - 2026)

Veracyte's Shares Outstanding history spans 14 years, with the latest figure at $79.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 2.04% to $79.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $79.4 million, a 2.04% increase, with the full-year FY2025 number at $79.4 million, up 2.04% from a year prior.
  • Shares Outstanding hit $79.4 million in Q4 2025 for Veracyte, roughly flat from $79.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for VCYT hit a ceiling of $79.4 million in Q4 2025 and a floor of $67.2 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $73.9 million across 5 years, with a median of $72.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 34.47% in 2021 and later increased 1.0% in 2022.
  • Tracing VCYT's Shares Outstanding over 5 years: stood at $71.1 million in 2021, then rose by 1.18% to $72.0 million in 2022, then rose by 1.81% to $73.3 million in 2023, then rose by 6.15% to $77.8 million in 2024, then increased by 2.04% to $79.4 million in 2025.
  • Business Quant data shows Shares Outstanding for VCYT at $79.4 million in Q4 2025, $79.0 million in Q3 2025, and $78.6 million in Q2 2025.